CSR's July Grant Lock-In: Doors Shut, Ideas Judged
Published Date: 6/6/2025
Notice
Summary
The Center for Scientific Review is holding several closed virtual meetings in July 2025 to review and evaluate grant applications. These meetings protect private info and trade secrets while deciding which research projects get funding. Scientists and small businesses applying for grants will be affected, with no direct cost changes but important deadlines to keep in mind.
Analyzed Economic Effects
3 provisions identified: 2 benefits, 0 costs, 1 mixed.
NIH closed virtual grant review meetings
If you applied for an NIH grant, the Center for Scientific Review will hold multiple closed virtual meetings to review and evaluate applications on July 1-2, 2025 and July 8-9, 2025. The meetings are closed to the public under 5 U.S.C. 552b(c)(4) and (c)(6) to protect confidential trade secrets, commercial property (such as patentable material), and personal information.
Small business pangenome panel review
If you are a small business applying to the 'Small Business: Informatics tools for the Pangenome' panel, your application will be reviewed in a closed virtual meeting on July 8, 2025. The meeting is closed to protect confidential commercial information and personal data.
Human Virome Program (RFA-RM-24-009) application review
Applicants to RFA-RM-24-009 (Human Virome Program: Developing novel and innovative tools to interrogate and annotate the human virome, U01, Clinical Trial Not Allowed) will have their applications reviewed in a closed virtual meeting on July 8, 2025. The meeting is closed to protect confidential commercial property and personal information.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16683, Proposed Collection; 60-Day Comment Request; Data Use Certification for the NIH National Institute on Drug Abuse Data Share Site
The purpose of this notice is to inform the public of the information collection requirement for the NIDA Data Share, the data use terms and conditions, and to request a progress report statement at the time of renewal. In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the National Institute on Drug Abuse (NIDA) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
2026-16544, Government-Owned Inventions; Availability for Licensing
The inventions listed below are owned by an agency of the U.S. Government and are available for licensing to achieve expeditious commercialization of results of federally-funded research for the benefit of the public health.
2026-16440, NIH Owned Invention Available for License: Soluble Tissue Factor, a Novel Target, and Antibodies, for Diagnosis, Prevention and Treatment of Thrombosis and Related Conditions
Scientists at the National Cancer Institute (NCI) have discovered a novel therapeutic, diagnostic and prognostic target for thrombosis: Soluble Tissue Factor (sTF). NCI has generated first-in- class antibodies and platform selectively neutralizing pathological coagulation while preserving normal hemostasis. This platform technology can be used to prevent, diagnose and treat pathological thrombosis caused by a variety of clinical conditions-including cancer, sepsis, infectious diseases (e.g., COVID), autoimmune disorders, trauma, heart conditions and inflammatory conditions. It offers a much more sensitive and specific test of thrombosis than the current D-dimer test. It may be applicable to any clinical condition which induces necroptosis, pyroptosis and NETtosis, such as cancer, neurodegenerative disease, ischemia-reperfusion and acute injuries, traumatic injuries, bacterial and viral infections, cardiovascular conditions, and atherosclerosis, inflammatory, autoimmune conditions, and others.
2026-16071, Proposed Collection; 60-Day Comment Request: The Impact of Clinical Research Training and Medical Education at the Clinical Center on Physician Careers in Academia and Clinical Research (Clinical Center)
In compliance with the requirement of the Paperwork Reduction Act of 1995, for opportunity for public comment on proposed data collection projects, the Clinical Center, the National Institutes of Health (NIH) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
2026-15565, Proposed Collection; 60-Day Comment Request, Data Use Certification for the NIH Brain Development Cohorts (NBDC) Data Hub, (National Institute on Drug Abuse)
In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the National Institute on Drug Abuse (NIDA) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval. The purpose of this revision is to update instructions for the Research Data Use Statement and the Progress Report, and to add new instructions for attesting to National Institute of Standards & Technology (NIST) security compliance, and for a Project Close-out at the time of project completion. Burden levels remain unchanged.
2026-14966, Government-Owned Inventions; Availability for Licensing
The National Institutes of Health is offering a new Ebola vaccine invention for companies to license and develop quickly. This vaccine targets the Bundibugyo virus and promises fast and lasting protection, helping stop outbreaks in Central Africa. Businesses interested in licensing should act soon to bring this life-saving tech to market and can contact NIH for details.
Previous / Next Documents
Previous: 2025-10337, Center for Scientific Review; Amended Notice of Meeting
The Center for Scientific Review changed the date of a special meeting about fellowships in brain and movement science from June 30–July 1 to July 29–30, 2025. This meeting is private and won’t be open to the public. Researchers and applicants involved should note the new schedule to stay on track with their plans.
Next: 2025-10339, Procurement List; Proposed Additions and Deletions
The government plans to add new services to its special shopping list that helps nonprofits employing people who are blind or have serious disabilities. At the same time, some products and services currently on the list will be removed. These changes help support good causes while keeping the list fresh and efficient.